Arvinas, Inc. (ARVN) stock
ARVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.76−0.06 (-0.81%)
Close on Nov 18, 2026Market cap $442.34MP/E 42.3Yield –
Arvinas gross margin
Gross margin is gross profit as a percentage of revenue.
No gross margin figures for Arvinas
Arvinas has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?